tolbutamide has been researched along with Insulinoma in 43 studies
Tolbutamide: A sulphonylurea hypoglycemic agent with actions and uses similar to those of CHLORPROPAMIDE. (From Martindale, The Extra Pharmacopoeia, 30th ed, p290)
tolbutamide : An N-sulfonylurea that consists of 1-butylurea having a tosyl group attached at the 3-position.
Insulinoma: A benign tumor of the PANCREATIC BETA CELLS. Insulinoma secretes excess INSULIN resulting in HYPOGLYCEMIA.
| Excerpt | Relevance | Reference |
|---|---|---|
| " This study investigated the interactions of calcium and somatostatin analogues on peptide release in two patients, one with a glucagonoma (patient A) and one with an insulinoma (patient B)." | 9.08 | Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma. ( O'Dorisio, TM; Thompson, CS; Woltering, EA, 1996) |
| "The phytostilbene resveratrol (RV) improves the metabolic state in animal models by increasing the insulin responsiveness of tissues and there is evidence that RV affects insulin secretion from native beta-cells and insulinoma cells." | 7.74 | Resveratrol inhibits electrical activity and insulin release from insulinoma cells by block of voltage-gated Ca+ channels and swelling-dependent Cl- currents. ( Bacová, Z; Geibel, J; Iglseder, E; Jakab, M; Lach, S; Langelüddecke, C; Paulmichl, M; Ritter, M; Schmidt, S; Strbák, V, 2008) |
| "The plasma glucose and insulin responses to intravenous administration of tolbutamide in patients with insulinoma and healthy control subjects were compared to determine the sensitivity and specificity of the intravenous tolbutamide test for the diagnosis of insulinoma." | 7.67 | Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. ( McMahon, MM; O'Brien, PC; Service, FJ, 1989) |
| "Thus, alpha-TC glucagonoma cells contain ATP-sensitive K+ channels that regulate glucagon release, yet allow inhibition of hormone release by glucose." | 5.29 | Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. ( Buettger, C; Epstein, AJ; Hang, TL; Matschinsky, FM; Ronner, P, 1993) |
| " This study investigated the interactions of calcium and somatostatin analogues on peptide release in two patients, one with a glucagonoma (patient A) and one with an insulinoma (patient B)." | 5.08 | Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma. ( O'Dorisio, TM; Thompson, CS; Woltering, EA, 1996) |
| "The phytostilbene resveratrol (RV) improves the metabolic state in animal models by increasing the insulin responsiveness of tissues and there is evidence that RV affects insulin secretion from native beta-cells and insulinoma cells." | 3.74 | Resveratrol inhibits electrical activity and insulin release from insulinoma cells by block of voltage-gated Ca+ channels and swelling-dependent Cl- currents. ( Bacová, Z; Geibel, J; Iglseder, E; Jakab, M; Lach, S; Langelüddecke, C; Paulmichl, M; Ritter, M; Schmidt, S; Strbák, V, 2008) |
| "The response of insulinoma tissue to glucose, alpha-ketoisocaproate, and the modifiers of insulin release, tolbutamide, isoproterenol, and acetylcholine, was studied." | 3.67 | Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas. ( Ferguson, DC; Hoenig, M; Matschinsky, FM, 1984) |
| "The plasma glucose and insulin responses to intravenous administration of tolbutamide in patients with insulinoma and healthy control subjects were compared to determine the sensitivity and specificity of the intravenous tolbutamide test for the diagnosis of insulinoma." | 3.67 | Diagnostic interpretation of the intravenous tolbutamide test for insulinoma. ( McMahon, MM; O'Brien, PC; Service, FJ, 1989) |
| "In order to clarify the mechanism of insulin secretion, responses of insulin (IRI) and C-peptide (CPR) in plasma to various stimuli were investigated in normal subjects and patients with diabetes mellitus, liver cirrhosis, chronic nephritis or insulinoma." | 3.66 | Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man. ( Kobayashi, T; Nihei, J; Ohneda, A; Sakai, T, 1982) |
| "Insulinomas are β-cell tumors that cause hypoglycemia through inappropriate secretion of insulin." | 1.42 | Human Insulinomas Show Distinct Patterns of Insulin Secretion In Vitro. ( Guiot, Y; Henquin, JC; Nenquin, M; Rahier, J; Sempoux, C, 2015) |
| " Moreover, the effectiveness of tolbutamide on [Ca(2+)](i) increase was reduced and the dose-response relations for insulin secretion induced by the agent was shifted toward the right in the UCP1-expressing cells." | 1.31 | Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells. ( Aso, K; Fukudome, M; Hashiguchi, H; Ishihara, H; Kakei, M; Koriyama, N; Nakazaki, M; Oka, Y; Tei, C; Yada, T, 2002) |
| " By applying the patch-clamp technique, dose-response curves for ATP and the sulfonylurea tolbutamide were obtained in inside-out patches." | 1.30 | RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin. ( Berggren, PO; Bränström, R; Höög, A; Larsson, O; Wahl, MA, 1997) |
| "Thus, alpha-TC glucagonoma cells contain ATP-sensitive K+ channels that regulate glucagon release, yet allow inhibition of hormone release by glucose." | 1.29 | Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells. ( Buettger, C; Epstein, AJ; Hang, TL; Matschinsky, FM; Ronner, P, 1993) |
| "Therefore, the hyperproinsulinemia of type 2 diabetes and in insulinoma patients may be caused by additional defects in the proinsulin to insulin conversion process." | 1.28 | Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin. ( Creutzfeldt, W; Nauck, MA; Siegel, EG, 1991) |
| "If a diagnosis of insulinoma is in doubt after several overnight fasts, C-peptide suppression test should be carried out since the test is safe and convenient." | 1.27 | [Studies on the diagnosis of insulinoma]. ( Kurihara, Y, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 17 (39.53) | 18.7374 |
| 1990's | 12 (27.91) | 18.2507 |
| 2000's | 12 (27.91) | 29.6817 |
| 2010's | 1 (2.33) | 24.3611 |
| 2020's | 1 (2.33) | 2.80 |
| Authors | Studies |
|---|---|
| Bahekar, RH | 1 |
| Jain, MR | 1 |
| Goel, A | 1 |
| Patel, DN | 1 |
| Prajapati, VM | 1 |
| Gupta, AA | 1 |
| Jadav, PA | 1 |
| Patel, PR | 1 |
| Zhao, L | 1 |
| Carmean, CM | 1 |
| Landeche, M | 1 |
| Chellan, B | 1 |
| Sargis, RM | 1 |
| Henquin, JC | 1 |
| Nenquin, M | 1 |
| Guiot, Y | 1 |
| Rahier, J | 2 |
| Sempoux, C | 1 |
| Mayer, SI | 1 |
| Thiel, G | 1 |
| Jakab, M | 2 |
| Lach, S | 1 |
| Bacová, Z | 1 |
| Langelüddecke, C | 1 |
| Strbák, V | 2 |
| Schmidt, S | 2 |
| Iglseder, E | 1 |
| Paulmichl, M | 2 |
| Geibel, J | 1 |
| Ritter, M | 2 |
| Cosgrove, KE | 2 |
| Antoine, MH | 1 |
| Lee, AT | 1 |
| Barnes, PD | 1 |
| de Tullio, P | 1 |
| Clayton, P | 1 |
| McCloy, R | 1 |
| De Lonlay, P | 1 |
| Nihoul-Fékété, C | 1 |
| Robert, JJ | 1 |
| Saudubray, JM | 1 |
| Lindley, KJ | 1 |
| Hussain, K | 1 |
| Aynsley-Green, A | 1 |
| Pirotte, B | 1 |
| Lebrun, P | 1 |
| Dunne, MJ | 3 |
| CREUTZFELDT, W | 2 |
| WILLE, K | 1 |
| KAUP, H | 1 |
| REESE, JL | 1 |
| KISER, WJ | 1 |
| MATASSARIN, BM | 1 |
| BLACK, KO | 1 |
| BIRNSTINGL, MA | 1 |
| MARRACK, D | 1 |
| ROSE, FC | 1 |
| MARKS, V | 2 |
| Merglen, A | 1 |
| Theander, S | 1 |
| Rubi, B | 1 |
| Chaffard, G | 1 |
| Wollheim, CB | 1 |
| Maechler, P | 1 |
| Al-Majed, HT | 1 |
| Squires, PE | 1 |
| Persaud, SJ | 1 |
| Huang, GC | 1 |
| Amiel, S | 1 |
| Whitehouse, BJ | 1 |
| Jones, PM | 1 |
| Grundbichler, M | 1 |
| Benicky, J | 1 |
| Ravasio, A | 1 |
| Chwatal, S | 1 |
| Fürst, J | 1 |
| Uebersax, R | 1 |
| Cananau, S | 1 |
| Beuret, P | 1 |
| Zahnd, G | 1 |
| Jara Albarrán, A | 1 |
| Caballero Asensi, A | 1 |
| García Peris, P | 1 |
| Coste, A | 1 |
| Toledano, E | 1 |
| Gorospe, C | 1 |
| Caviola, E | 1 |
| Palacios Mateos, JM | 1 |
| Hoenig, M | 1 |
| Ferguson, DC | 1 |
| Matschinsky, FM | 2 |
| Ohneda, A | 2 |
| Kobayashi, T | 2 |
| Nihei, J | 2 |
| Kazeĭ, NS | 1 |
| Khar'kovaia, VV | 1 |
| Petrukhin, VI | 1 |
| Tsaguriia, EG | 1 |
| Sakai, T | 1 |
| Matsumoto, K | 1 |
| Fukunaga, K | 1 |
| Miyazaki, J | 2 |
| Shichiri, M | 1 |
| Miyamoto, E | 1 |
| Khan, RN | 1 |
| Hales, CN | 1 |
| Ozanne, SE | 1 |
| Adogu, AA | 1 |
| Ashford, ML | 1 |
| Sekine, N | 1 |
| Yamashita, N | 1 |
| Kojima, I | 1 |
| Ogata, E | 1 |
| Ronner, P | 1 |
| Hang, TL | 1 |
| Epstein, AJ | 1 |
| Buettger, C | 1 |
| Sjöholm, A | 1 |
| Arkhammar, P | 1 |
| Welsh, N | 1 |
| Bokvist, K | 1 |
| Rorsman, P | 1 |
| Hallberg, A | 1 |
| Nilsson, T | 1 |
| Welsh, M | 1 |
| Berggren, PO | 2 |
| Thompson, CS | 1 |
| O'Dorisio, TM | 1 |
| Woltering, EA | 1 |
| Khoo, S | 1 |
| Cobb, MH | 1 |
| Bränström, R | 1 |
| Höög, A | 1 |
| Wahl, MA | 1 |
| Larsson, O | 1 |
| Tian, YA | 1 |
| Johnson, G | 1 |
| Ashcroft, SJ | 1 |
| Chapman, JC | 1 |
| McClenaghan, NH | 1 |
| Hashmi, MN | 1 |
| Shepherd, RM | 1 |
| Giesberts, AN | 1 |
| White, SJ | 1 |
| Ammälä, C | 1 |
| Flatt, PR | 1 |
| Kulkarni, RN | 1 |
| Wang, ZL | 1 |
| Wang, RM | 1 |
| Smith, DM | 1 |
| Ghatei, MA | 1 |
| Bloom, SR | 1 |
| Su, J | 1 |
| Yu, H | 1 |
| Lenka, N | 1 |
| Hescheler, J | 1 |
| Ullrich, S | 1 |
| Park, KH | 1 |
| Kim, SW | 1 |
| Bae, YH | 1 |
| Sheader, EA | 1 |
| Brown, PD | 1 |
| Best, L | 1 |
| Nakazaki, M | 1 |
| Kakei, M | 1 |
| Ishihara, H | 1 |
| Koriyama, N | 1 |
| Hashiguchi, H | 1 |
| Aso, K | 1 |
| Fukudome, M | 1 |
| Oka, Y | 1 |
| Yada, T | 1 |
| Tei, C | 1 |
| Nauck, MA | 1 |
| Siegel, EG | 1 |
| Yule, DI | 1 |
| Gallacher, DV | 1 |
| Petersen, OH | 1 |
| Thivolet, CH | 1 |
| Demidem, A | 1 |
| Haftek, M | 1 |
| Durand, A | 1 |
| Bertrand, J | 1 |
| McMahon, MM | 1 |
| O'Brien, PC | 1 |
| Service, FJ | 1 |
| Grimaldi, KA | 1 |
| Siddle, K | 1 |
| Hutton, JC | 1 |
| Gorini, M | 1 |
| Ghizzi, A | 1 |
| Carlo Stella, C | 1 |
| De Caro, L | 1 |
| Kurihara, Y | 1 |
| Sinagra, D | 1 |
| Randazzo, C | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| TArgeting Type 1 Diabetes Using POLyamines (TADPOL): A Randomized, Double-Masked, Placebo-Controlled Phase 2 Study to Evaluate the Efficacy and Safety of Difluoromethylornithine (DFMO) to Preserve Insulin Production in Type 1 Diabetes[NCT05594563] | Phase 2 | 70 participants (Anticipated) | Interventional | 2023-03-14 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for tolbutamide and Insulinoma
| Article | Year |
|---|---|
[Diagnostic and therapeutic use of the artificial endocrine pancreas in hypoglycemia].
Topics: Humans; Hypoglycemia; Insulin Infusion Systems; Insulinoma; Monitoring, Physiologic; Pancreatic Neop | 1988 |
1 trial available for tolbutamide and Insulinoma
| Article | Year |
|---|---|
Calcium reverses octreotide inhibition of insulin and glucagon levels in patients with insulinoma and glucagonoma.
Topics: Antineoplastic Agents, Hormonal; Calcium; Glucagon; Glucagonoma; Humans; Hypoglycemic Agents; Infusi | 1996 |
41 other studies available for tolbutamide and Insulinoma
| Article | Year |
|---|---|
Design, synthesis, and biological evaluation of substituted-N-(thieno[2,3-b]pyridin-3-yl)-guanidines, N-(1H-pyrrolo[2,3-b]pyridin-3-yl)-guanidines, and N-(1H-indol-3-yl)-guanidines.
Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Design; Drug Evaluation, Preclinic | 2007 |
Selenomethionine modulates insulin secretion in the MIN6-K8 mouse insulinoma cell line.
Topics: Animals; Calcium; Cell Death; Cell Line, Tumor; Cell Survival; Gene Expression Regulation, Neoplasti | 2021 |
Human Insulinomas Show Distinct Patterns of Insulin Secretion In Vitro.
Topics: Adult; Aged, 80 and over; Calcium Chloride; Diazoxide; Female; Gene Expression Regulation; Glucose; | 2015 |
Calcium influx into MIN6 insulinoma cells induces expression of Egr-1 involving extracellular signal-regulated protein kinase and the transcription factors Elk-1 and CREB.
Topics: Animals; Calcium; Cell Line, Tumor; Cyclic AMP Response Element-Binding Protein; Dual Specificity Ph | 2009 |
Resveratrol inhibits electrical activity and insulin release from insulinoma cells by block of voltage-gated Ca+ channels and swelling-dependent Cl- currents.
Topics: Animals; Calcium Channels; Chloride Channels; Glucose; Insulin; Insulin Secretion; Insulinoma; Ion C | 2008 |
BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
Topics: Adenosine Triphosphate; Adolescent; Adrenergic alpha-Antagonists; Animals; Benzofurans; Benzothiadia | 2002 |
[Intravenous injections of glucose, insulin and tolbutamide in healthy persons, diabetics, cirrhotics, and patients with insuloma (together with a contribution on the diagnostic value of the tolbutamide tests)].
Topics: Adenoma, Islet Cell; Blood Glucose; Diabetes Mellitus; Glucose; Glucose Tolerance Test; Humans; Inje | 1962 |
ISLET CELL ADENOMA. INSULINOMAS AND THE INTRAVENOUS SODIUM TOLBUTAMIDE TEST: A CASE REPORT.
Topics: Adenoma, Islet Cell; Blood Chemical Analysis; Glucose Tolerance Test; Humans; Insulinoma; Pancreatic | 1964 |
INSULINOMA WITH SYMPTOMS FOR THIRTY YEARS.
Topics: Adenoma, Islet Cell; Blood Glucose; Fasting; Geriatrics; Glucose Tolerance Test; Humans; Hypoglycemi | 1964 |
Glucagon and tolbutamide tests in the recognition of insulinomas.
Topics: Adenoma, Islet Cell; Blood Glucose; Glucagon; Humans; Insulinoma; Pancreatic Neoplasms; Tolbutamide | 1961 |
Glucose sensitivity and metabolism-secretion coupling studied during two-year continuous culture in INS-1E insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Cell Differentiation; Cell Division; Cytosol; Diazoxide; E | 2004 |
Effect of 17beta-estradiol on insulin secretion and cytosolic calcium in Min6 mouse insulinoma cells and human islets of Langerhans.
Topics: Animals; Calcium; Cell Line, Tumor; Cytosol; Estradiol; Glucose; Humans; Hypoglycemic Agents; Insuli | 2005 |
Glucose induces anion conductance and cytosol-to-membrane transposition of ICln in INS-1E rat insulinoma cells.
Topics: 3-O-Methylglucose; Animals; Anions; Cell Line, Tumor; Cell Membrane; Cytosol; Fluorescence Resonance | 2006 |
[Insulinoma: what symptomatology?].
Topics: Adenoma, Islet Cell; Humans; Hypoglycemia; Insulin Coma; Insulinoma; Male; Middle Aged; Pancreatic N | 1984 |
[Tolbutamide plus somatostatin test in the diagnosis of insulinomas].
Topics: Adenoma, Islet Cell; Adult; Blood Glucose; Female; Humans; Hypoglycemia; Insulin; Insulinoma; Middle | 1982 |
Pharmacological modifications of insulin release in vitro from fuel-responsive transplantable insulinomas.
Topics: Acetylcholine; Adenoma, Islet Cell; Animals; Blood Glucose; Glucagon; Glucose; Insulin; Insulinoma; | 1984 |
Plasma insulin response to various secretagogues in insulinoma.
Topics: Adenoma, Islet Cell; Adult; Aged; Arginine; Blood Glucose; Child; Fasting; Female; Glucagon; Glucose | 1982 |
[Insulin-producing tumor of the pancreas].
Topics: Adenoma, Islet Cell; Adult; Diagnosis, Differential; Fasting; Humans; Hypoglycemia; Insulinoma; Male | 1982 |
Analysis of insulin secretion based on changes in plasma insulin and C-peptide in man.
Topics: Adult; Aged; Arginine; C-Peptide; Diabetes Mellitus; Female; Glucagon; Glucose Tolerance Test; Human | 1982 |
Ca2+/calmodulin-dependent protein kinase II and synapsin I-like protein in mouse insulinoma MIN6 cells.
Topics: Animals; Autoradiography; Calcium; Calcium-Calmodulin-Dependent Protein Kinases; Electrophoresis, Po | 1995 |
Dissociation of KATP channel and sulphonylurea receptor in the rat clonal insulin-secreting cell line, CRI-D11.
Topics: 1-Methyl-3-isobutylxanthine; Adenosine Triphosphate; Animals; ATP-Binding Cassette Transporters; Cel | 1993 |
Bimodal effect of transforming growth factor-beta on insulin secretion in MIN6 cells.
Topics: Animals; Colforsin; Dose-Response Relationship, Drug; Glucose; Humans; Insulin; Insulin Secretion; I | 1994 |
Sulfonylurea-binding sites and ATP-sensitive K+ channels in alpha-TC glucagonoma and beta-TC insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Binding Sites; Binding, Competitive; Diazoxide; Glucagon; Glucagono | 1993 |
Enhanced stimulus-secretion coupling in polyamine-depleted rat insulinoma cells. An effect involving increased cytoplasmic Ca2+, inositol phosphate generation, and phorbol ester sensitivity.
Topics: Adenosine Triphosphate; Animals; Calcium; Calcium Channels; Carbachol; Cytoplasm; Diazoxide; DNA, Ne | 1993 |
Activation of mitogen-activating protein kinase by glucose is not required for insulin secretion.
Topics: Animals; Calcium-Calmodulin-Dependent Protein Kinases; Colforsin; Deoxyglucose; Enzyme Activation; E | 1997 |
RIN14B: a pancreatic delta-cell line that maintains functional ATP-dependent K+ channels and capability to secrete insulin under conditions where it no longer secretes somatostatin.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Animals; Diazoxide; Electrophysiology; Insulin; Insul | 1997 |
Sulfonylureas enhance exocytosis from pancreatic beta-cells by a mechanism that does not involve direct activation of protein kinase C.
Topics: Animals; Calcium; Enzyme Activation; Exocytosis; Glyburide; Guanosine 5'-O-(3-Thiotriphosphate); Hyp | 1998 |
ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adrenergic alpha-Antagonists; Animals; Benzofurans; C | 1999 |
Glibenclamide but not other sulphonylureas stimulates release of neuropeptide Y from perifused rat islets and hamster insulinoma cells.
Topics: Animals; Blotting, Northern; Cricetinae; Glyburide; Hypoglycemic Agents; Insulin; Insulin Secretion; | 2000 |
The expression and regulation of depolarization-activated K+ channels in the insulin-secreting cell line INS-1.
Topics: 1-Methyl-3-isobutylxanthine; 4-Aminopyridine; 8-Bromo Cyclic Adenosine Monophosphate; Action Potenti | 2001 |
Interaction of sulfonylurea-conjugated polymer with insulinoma cell line of MIN6 and its effect on insulin secretion.
Topics: Acrylic Resins; Animals; Biocompatible Materials; Culture Media, Conditioned; Diazoxide; Glucose; Gl | 2001 |
Swelling-induced changes in cytosolic [Ca2++] in insulin-secreting cells: a role in regulatory volume decrease?
Topics: 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Animals; Calcium; Calcium Channel Blockers; Calciu | 2001 |
Association of upregulated activity of K(ATP) channels with impaired insulin secretion in UCP1-expressing insulinoma cells.
Topics: Adenosine Triphosphate; Animals; Calcium; Carrier Proteins; Cytosol; Gene Expression Regulation, Neo | 2002 |
Prolonged maximal stimulation of insulin secretion in healthy subjects does not provoke preferential release of proinsulin.
Topics: Adult; C-Peptide; Diabetes Mellitus, Type 2; Female; Glucagon; Humans; Hyperglycemia; Insulin; Insul | 1991 |
Effects of alanine on insulin-secreting cells: patch-clamp and single cell intracellular Ca2+ measurements.
Topics: Alanine; Animals; Calcium; Cell Membrane; Glucose; Insulin; Insulin Secretion; Insulinoma; Kinetics; | 1990 |
Structure, function, and immunogenicity of human insulinoma cells.
Topics: 1-Methyl-3-isobutylxanthine; Adenoma, Islet Cell; Adult; C-Peptide; Fluorescent Antibody Technique; | 1988 |
Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
Topics: Adenoma, Islet Cell; Blood Glucose; Body Weight; Evaluation Studies as Topic; Female; Glucose Tolera | 1989 |
Diagnosis and differential diagnosis of hypoglycemia.
Topics: Blood Glucose; Diagnosis, Differential; False Positive Reactions; Glucose Tolerance Test; Humans; Hy | 1989 |
Biosynthesis of insulin secretory granule membrane proteins. Control by glucose.
Topics: Adenoma, Islet Cell; Animals; Calcium; Chemical Precipitation; Cytoplasmic Granules; Glucose; Immuno | 1987 |
[Biochemical diagnosis of insulinoma: correlations between blood glucose, blood insulin and the titer of plasma non-esterified fatty acids during fasting and during various diagnostic tests].
Topics: Adenoma, Islet Cell; Adult; Aged; Blood Glucose; C-Peptide; Epinephrine; Fasting; Fatty Acids, Nones | 1985 |
[Studies on the diagnosis of insulinoma].
Topics: Adenoma, Islet Cell; Adolescent; Adult; Aged; Blood Glucose; C-Peptide; Female; Glucagon; Humans; In | 1987 |